This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
12 Aug 2014 | Asia Pacific | Market Research
Malaysia Healthcare Outlook
Showcasing Value Propositions for Investors
The Malaysia healthcare outlook addresses the investment opportunities across various segments. The study explores the developments in the hospital industry, IVD and POCT industry, pharmaceutical industry, biotechnology industry, medical devices industry, connected health industry, and the aged care industry in the country. The study explores oppor...
$3,950.00 -
04 Aug 2014 | Global | Market Research
2014 New Product Innovation Leadership Award in The Point of Care Diagnostics for the Emergency Medicine Industry
$1,500.00 -
04 Aug 2014 | Global | Market Research
Vital Signs - Healthcare News - The Analysts Perspective - July Issue
This issue of Vital Signs, released on August 5, 2014, discusses the Senators plead to the FDA for the quick action regarding draft guidance on laboratory developed tests (LDTs), Synthetic Biologys Series A funding round, Roches investment in Stratos Genomics, and Indias cap on drug prices.
$500.00 -
24 Jul 2014 | Asia Pacific | Market Research
Emerging Pharma Trends that will Revolutionize the Healthcare Landscape in the Asia Pacific
This issue of Vital Signs, released on July 24, 2014, discusses emerging pharma trends in the Asia Pacific and how the region will act as an anchor to global pharma in coming years, especially in segments such as manufacturing, R&D and clinical trials.
$500.00 -
22 Jul 2014 | North America | Market Research
Analysis of the Global In Vitro Diagnostics Market
Slowing US and European Markets Demand Alignment with Global Market Needs
Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. The global IVD market size was $47.30 billion in 2013; it is expected to reach $62.63 billion in 2017, at a compound annual growth rate of 7.3%. Because of stagnating mature markets, comp...
$4,950.00 -
14 Jul 2014 | Europe | Market Research
Analysis of the European Breast Imaging Systems Market
Trends and Dynamics of the Breast Imaging Systems Market in Western Europe
This research service provides an in-depth analysis of the European breast imaging systems market. It analyses the revenue potential, market dynamics, and trends across countries in Western Europe. Market revenues have been derived from studying the dynamics of different segments which include: X-ray mammography, breast ultrasound, breast magnetic...
$3,950.00 -
11 Jul 2014 | Global | Market Research
Will Virtual CROs and Integrated Business Models Rule the Road
Insights into the innovative steps taken by CROs and pharmaceutical companies in the race for excellence and low-cost trials
This issue of Vital Signs, released on July 11, 2014, discusses game changing strategies in clinical research, including virtual clinical research organization (CRO) and the integrated business model.
$450.00 -
10 Jul 2014 | North America | Market Research
Analysis of the US Molecular Imaging Informatics Market
Growth Opportunities in Nuclear and PET Imaging Informatics Subsist Despite Downward Pressures on Equipment Markets
This study provides an analysis of the US market for molecular imaging informatics solutions including nuclear imaging informatics, PET imaging informatics, and multimodality image fusion and comparison. The study assesses the size of the market based on its historic growth between 2010 and 2013, and projects future growth based on the current driv...
$2,450.00 -
03 Jul 2014 | Global | Market Research
A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS
Antiretroviral Combinations Continue to Transform the Treatment Landscape
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...
$3,950.00 -
01 Jul 2014 | Global | Market Research
Vital Signs - Healthcare News - The Analysts Perspective - June 2014
This issue of Vital Signs, released on July 1, 2014, discusses the FDA approval of Biogens Eloctate, Qiagens acquisition of Primera Dx, Roches acquisition of Genia Technologies, Cues at-home connected lab test, and the Credihealth Teen Clinic.
$450.00
